Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Ultimovacs

Request full access

A pharmaceutical company developing novel immunotherapies against cancer

Oslo, NorwayFounded 2011Biotech & Life Sciences

At a glance

Status
Listed
Founded
2011
Headquarters
Oslo, Norway
Listing
IPO 2019
Sector
Biotech & Life Sciences
Outcome tier
Thoroughbred$100M+ revenue

Ultimovacs in the Oslo ecosystem

Live from Dealroom

The Ultimovacs office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

  • Uppsala University

Ownership

Share of equity by holder

Share of equity by holder, from Dealroom's shareholder data. Stakes as last recorded by Dealroom (2026).

18.9% GJELSTEN HOLDING AS

“Other / undisclosed” is the 52.5% not attributed to a named shareholder. See the full cap table on Dealroom →

Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇳🇴 Norway90.1%
🇸🇪 Sweden17%
2 countries shown
Web traffic by country
330 monthly visits
across markets
🇺🇸 United States60.6%
🇬🇧 United Kingdom30.3%
Top 2 markets shown

Patents

Estimated portfolio value
$14M

4 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Ultimovacs on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Ultimovacs on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.